NetFind Web Search

Search results

1. Results From The WOW.Com Content Network

2. Exact Sciences Corp. - Wikipedia

   en.wikipedia.org/wiki/Exact_Sciences_Corp.

   Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown ...

3. Guardant's blood-based cancer test moves closer to Medicare ...

   www.aol.com/news/us-fda-approves-guardant-health...

   Exact Sciences' stool test Cologuard had a 92.3% sensitivity rate. Colorectal cancer occurs in about 150,000 patients in the U.S. annually and is the second-leading cause of cancer fatalities in ...

4. U.S. FDA advisers back approval for Guardant's blood-based ...

   www.aol.com/news/u-fda-advisers-back-approval...

   Guardant's application for Shield was based on a study that showed the test detected 83% of colorectal cancers, while Exact's Cologuard had 92.3% sensitivity rate, according to the FDA's documents.

5. Top-Line Data Show Exact Sciences' Cologuard Test ...

   www.aol.com/news/2013-04-18-top-line-data-show...

   Top-Line Data Show Exact Sciences' Cologuard Test Demonstrates 92 Percent Sensitivity in the Detection of Colorectal Cancer All endpoints achieved in 10,000-patient trial of non-invasive ...

6. File:Exact Sciences Lab, Madison WI.jpg - Wikipedia

   en.wikipedia.org/wiki/File:Exact_Sciences_Lab...

   You are free: to share – to copy, distribute and transmit the work; to remix – to adapt the work; Under the following conditions: attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made.

7. What Exactly Should Investors Do With Exact Sciences? - AOL

   www.aol.com/news/2013-07-15-what-exactly-should...

   Year-to-date gains of 25% don't really tell the full story for molecular diagnostics company Exact Sciences . There have been plenty of big ups and downs to get to those 25% gains. Since late ...